Unsubscribe

I’ll be straightforward.

Earlier today, we sent an email extending the MarketBeat All Access offer by one additional day. That wasn’t originally part of the plan, and I wasn’t immediately convinced it was the right move.

After reviewing the feedback and the response, it turned out to be a good idea.

I also noticed you didn’t take advantage of the original offer. Maybe you’re still deciding. Maybe you’re not sure if it’s worth it. I get it.

So I’m making this clear personally: this extension ends tonight at midnight.

Start your 30-day trial before midnight tonight

This is your final opportunity to try MarketBeat All Access risk-free. If you’ve been on the fence, the 30-day trial exists for exactly this reason. Try it free, then pay just $99 for the entire year instead of $399. If you don’t like it, you never get charged. Cancel anytime.

Use the platform, see how it fits your investing process, and decide from there.

All Access includes AI-powered research, real-time portfolio alerts, analyst ratings from 50+ Wall Street firms, advanced screeners, and premium research.

START YOUR TRIAL NOW

After tonight, this offer is closed.

Matthew Paulson
Founder & CEO, MarketBeat

P.S. Midnight tonight is the final cutoff. No more extensions. Try it risk-free for 30 days.

Thank you for subscribing to MarketBeat!

We empower investors to make better investment decisions by offering up-to-the-minute financial information and unbiased market analysis.

If you have questions or concerns about your newsletter, feel free to contact our U.S. based support team at contact@marketbeat.com.

If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.

© 2006-2026 MarketBeat Media, LLC. All rights protected.
345 N Reid Pl., Suite 620, Sioux Falls, S.D. 57103. USA..

See Also: 5 Stocks That Could Double in 2026 (Click to Opt-In)